Prime Islami Life Insurance Limited (DSE: PRIMELIFE)
Bangladesh
· Delayed Price · Currency is BDT 42.90
+1.40 (3.37%)
At close: Sep 10, 2024
PRIMELIFE Income Statement
Financials in millions BDT. Fiscal year is January - December.
Millions BDT. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Premiums & Annuity Revenue | 3,971 | 4,036 | 4,130 | 4,273 | 4,120 | 3,633 | Upgrade
|
| Total Interest & Dividend Income | 33.56 | 82.75 | 111.77 | 132.06 | -21.74 | -5.59 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -1.3 | -5.15 | - | -0.7 | Upgrade
|
| Other Revenue | 5.04 | 5.03 | 2.18 | 5.68 | 3.47 | 115.36 | Upgrade
|
| Total Revenue | 4,009 | 4,124 | 4,242 | 4,406 | 4,102 | 3,742 | Upgrade
|
| Revenue Growth (YoY) | -4.48% | -2.79% | -3.71% | 7.40% | 9.63% | -7.78% | Upgrade
|
| Policy Benefits | 2,892 | 2,999 | 2,996 | 2,946 | 2,813 | 2,268 | Upgrade
|
| Policy Acquisition & Underwriting Costs | 501.95 | 501.95 | 576.48 | 623.03 | 592.62 | 482.62 | Upgrade
|
| Depreciation & Amortization | 20.06 | 20.06 | 22.63 | 24.38 | 17.81 | 18.23 | Upgrade
|
| Selling, General & Administrative | 229.62 | 274.67 | 352.19 | 380.45 | 385.97 | 339.55 | Upgrade
|
| Provision for Bad Debts | 51.94 | 51.94 | 0.5 | 1.35 | 1.34 | - | Upgrade
|
| Other Operating Expenses | 4.1 | 6.93 | 10.81 | 19.65 | 7.94 | 42.14 | Upgrade
|
| Total Operating Expenses | 4,194 | 4,349 | 4,474 | 4,541 | 4,420 | 3,745 | Upgrade
|
| Operating Income | -184.98 | -224.64 | -231.67 | -134.77 | -318.22 | -2.71 | Upgrade
|
| Interest Expense | -9.41 | -9.41 | -19.96 | -17.71 | -14.03 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -12.41 | -12.41 | -14.79 | -16.48 | -14.3 | -29.68 | Upgrade
|
| EBT Excluding Unusual Items | -206.81 | -246.47 | -266.41 | -168.96 | -346.55 | -32.39 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.13 | 0.13 | - | - | - | - | Upgrade
|
| Asset Writedown | -2.84 | -2.84 | -43.07 | -7.34 | - | - | Upgrade
|
| Other Unusual Items | -0.6 | -0.6 | -1.25 | - | -15 | -9 | Upgrade
|
| Pretax Income | -210.12 | -249.78 | -310.73 | -176.3 | -361.55 | -41.39 | Upgrade
|
| Income Tax Expense | 2.53 | 2.53 | 53.3 | 83.64 | 128.92 | 25.83 | Upgrade
|
| Earnings From Continuing Ops. | -212.65 | -252.31 | -364.03 | -259.94 | -490.47 | -67.22 | Upgrade
|
| Minority Interest in Earnings | -7.04 | 13.71 | 6.69 | -10.59 | 35.43 | 43.53 | Upgrade
|
| Net Income | -219.69 | -238.6 | -357.34 | -270.53 | -455.04 | -23.68 | Upgrade
|
| Net Income to Common | -219.69 | -238.6 | -357.34 | -270.53 | -455.04 | -23.68 | Upgrade
|
| Shares Outstanding (Basic) | 31 | 31 | 31 | 31 | 31 | 31 | Upgrade
|
| Shares Outstanding (Diluted) | 31 | 31 | 31 | 31 | 31 | 31 | Upgrade
|
| EPS (Basic) | -7.20 | -7.82 | -11.71 | -8.86 | -14.91 | -0.78 | Upgrade
|
| EPS (Diluted) | -7.20 | -7.82 | -11.71 | -8.86 | -14.91 | -0.78 | Upgrade
|
| Free Cash Flow | 208.51 | 93.76 | -122.82 | -120.98 | -77.42 | -476.45 | Upgrade
|
| Free Cash Flow Per Share | 6.83 | 3.07 | -4.02 | -3.96 | -2.54 | -15.61 | Upgrade
|
| Dividend Per Share | - | - | 0.200 | - | - | 1.000 | Upgrade
|
| Dividend Growth | - | - | - | - | - | -16.67% | Upgrade
|
| Operating Margin | -4.61% | -5.45% | -5.46% | -3.06% | -7.76% | -0.07% | Upgrade
|
| Profit Margin | -5.48% | -5.79% | -8.42% | -6.14% | -11.09% | -0.63% | Upgrade
|
| Free Cash Flow Margin | 5.20% | 2.27% | -2.89% | -2.75% | -1.89% | -12.73% | Upgrade
|
| EBITDA | - | -211.89 | -216.28 | -117.2 | -300.41 | 15.52 | Upgrade
|
| EBITDA Margin | - | -5.14% | -5.10% | -2.66% | -7.32% | 0.41% | Upgrade
|
| D&A For EBITDA | - | 12.76 | 15.39 | 17.57 | 17.81 | 18.23 | Upgrade
|
| EBIT | -184.98 | -224.64 | -231.67 | -134.77 | -318.22 | -2.71 | Upgrade
|
| EBIT Margin | -4.61% | -5.45% | -5.46% | -3.06% | -7.76% | -0.07% | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.